As GLP-1 drugs like Eli Lilly’s Mounjaro and Novo Nordisk’s Ozempic and Wegovy have spent the last couple of years skyrocketing in popularity—with no signs of slowing down—it was perhaps only a matter ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...

Is using GLP-1s for weight loss really "cheating"? What do these medicines actually do, why do users feel they should keep it ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

Pasireotide frequently causes severe hyperglycemia; however, its detailed mechanism remains unknown. There are no published guidelines regarding the optimal management of pasireotide-induced ...

More people are paying out-of-pocket for GLP-1 weight loss drugs — and more retailers are offering discounts on Zepbound, Ozempic, and Wegovy. Walmart will offer in-store pickup for Zepbound at ...

New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the future.

This large community-based cohort study investigates the impact of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), specifically Liraglutide and Semaglutide, on the risk of developing ...

GLP-1 medicines don't just change your body. They also reshape how you think, feel, and relate. Here is what the science says ...